Activity, Balance and COPD (ABCOPD)
- Conditions
- COPD
- Interventions
- Other: No intervention being delivered.
- Registration Number
- NCT04006015
- Lead Sponsor
- Imperial College London
- Brief Summary
This research project incorporates a series of studies to investigate the relationship between physical performance (e.g. tests of strength, balance and walking distance) and physical activity (activity measured in day to day life) in people with COPD and other chronic lung diseases.
- Detailed Description
The research project incorporates the following components:
Study 1) A prospective, observational study, to assess the relationship between a comprehensive set of measures of walking ability, strength and balance, and daily physical activity in people with chronic lung disease. Patients will attend a single assessment session to evaluate physical capacity. They will also wear a physical activity monitor for a week following completing these tests to assess physical activity and aspects of physical performance. Participants will also be invited to return two months later to provide evidence about the repeatability of measurements.
Study 2) A parallel study comparing assessment of performance during six-minute walk tests by an observer to a semi-automated assessment using an activity monitor worn by the patient. This will involve a single visit and be carried out during walking tests carried out as part of routine clinical care.
Study 3) A qualitative study to investigate experiences and perceptions of participants of dance groups for people with chronic lung disease, as a novel form of physical activity. This will be used to inform the design of subsequent trials of dance interventions for chronic lung disease.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 82
- Adults with stable chronic lung disease
- Able to understand instructions.
- Age and sex matched healthy controls.
- For the main study, the presence of other comorbidities causing a significant reduction in mobility (for example stroke with neurological deficits, severe arthritis, significant peripheral neuropathy, significant visual impairment, dementia etc.).
- exacerbation of lung disease within the last 2 months.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Qualitative dance substudy No intervention being delivered. We will aim for 20 participants. Main study group No intervention being delivered. 31 people with COPD and 31 controls in the main study group. six-minute walk substudy No intervention being delivered. We will aim to have 40 participants participating in the 6 minute walk sub-study.
- Primary Outcome Measures
Name Time Method Free-living gait stability as assessed by activity monitor 7 days. The free-living gait stability parameters derived from the fixed body sensor worn during activity monitoring at home.
- Secondary Outcome Measures
Name Time Method Timed Up and Go (TUG) Assessed during a single clinical assessment at baseline. Time in seconds to complete the standard TUG protocol
Physical performance assessment Assessed during single clinical assessment at baseline. Assessed using the Short Physical Performance Battery (SPPB) in clinical setting.
Balance confidence Assessed during a single clinical assessment at baseline. Assessed using the Activities-specific Balance Confidence (ABC) scale. This is a self completed measure of balance confidence during common activities of daily living. It includes 16 questions which participant give a percentage confidence response with 0% being not confident at all and 100% being completely confident. There is also a total score out from 0% (least confident) to 100% (most confident) for overall balance confidence, which average created by combining the scores given for the separate questions.
Clinical balance assessment Assessed during single clinical assessement at baseline. Assessed using the miniBESTest in clinical setting.
Physical activity assessed by step count using activity monitor 7 days. Physical activity assessed using step count (number of steps), as assessed using the activity monitor at home (McRoberts MoveMonitor).
Walking distance in metres Assessed during a single clinical assessment at baseline. Assessed using the six-minute walk test in clinical setting.
Patient experience as assessed by semi-structured interviews 1 hour. The patients experience assessed by semi-structured interviews in focus group.
Physical Activity: Movement intensity (in average body acceleration (g) during activity) 7 days. Movement intensity measurement is assessed using the fixed body sensor worn during activity monitoring at home.
Physical activity: types of activity (time in minutes spent standing, walking, lying, sitting, cycling, running) assessed with activity monitor. 7 days. Types of activity (time measured in minutes spent standing, walking, lying, sitting, cycling, running) is assessed using the fixed body sensor worn during activity monitoring at home.
Functional reach test Assessed during a single clinical assessment at baseline. Assessed using standard functional reach protocol
Trial Locations
- Locations (1)
National Heart and Lung Institute, Imperial College London
🇬🇧London, United Kingdom